Dechra To Showcase Sporimune® - A New Treatment To Tackle Canine Atopic Dermatitis At London Vet Show

Delegates to the London Vet Show will be able to discover more about a new-to-the-market treatment from Dechra Veterinary Products during the event this week. Dechra will be showcasing Sporimune®, its new treatment to tackle canine atopic dermatitis, at the event at Olympia Grand on November 20 and 21. Visitors will also be able to find out more about the UK's only vet-licensed methadone, Comfortan®, a key product in Dechra's anaesthesia and analgesia portfolio. Sporimune® is an easy dispensing, flexible dosing ciclosporin that is licensed for the treatment of chronic manifestations of atopic dermatitis. It is the latest product unveiled as part of Dechra's Partners in Practice Programme to support vets in first opinion practice. Larry King, Marketing Manager at Dechra Veterinary Products, said: “The London Vet Show is a key date in our calendar when we can meet and engage with veterinary professionals. “Our team will be on hand to explain how Sporimune and Comfortan can benefit veterinary practices and patients alike.” Dechra is also taking part in the show’s Safari competition, where visitors stand a chance of winning a 12-day trip to Borneo with Worldwide Veterinary Services, by getting a ‘passport’ stamped at stands including the Dechra stand, E34.

More from

• IVC Evidensia assembles expert team to run new £10m referral hospital
• Home delivery service can increase pet health plan sign-ups by 25%
• Research reveals vital clues to help fight anthelmintic resistance
• Lifetime Achievement Award recognises Harrogate vet’s dedication to improving the health and welfare of rabbits
• Bake sale at Leicestershire vet practice for good cause